Arrowhead Pharmaceuticals (ARWR) Competitor Comparison
We are evaluating the key criteria listed to compare Arrowhead Pharmaceuticals (ARWR) against its competitors in the Biotechnology industry.
Market Capitalization
45 / 368Gross Profits
27 / 278Total Revenue
48 / 300EBITDA
280 / 337Free Cashflow
333 / 352Quick Ratio
233 / 357Earnings per Share
294 / 359Dividend yield
0 / 6Total Cash
76 / 358Performance 3 years
205 / 368Performance 5 years
184 / 368Performance 10 years
31 / 368Linearity 3 years
156 / 368Linearity 5 years
92 / 368Linearity 10 years
153 / 368Total Rank
174 / 368Dividend Rank
362 / 368Valuation Rank
277 / 368Piotroski Rank
193 / 368Muliplier Rank
279 / 368Gross Profits - ARWR ranking 27 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.